Capricor Therapeutics (CAPR) Stock
Capricor Therapeutics (CAPR) has a Tenet Score of 51 of 100 against 409 Healthcare peers, as of Nov 16, 2026.
Key stats
- Market cap
- $529.1M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 2.96 – 40.37
- low → high
- Tenet Score
- 51/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Capricor Therapeutics Inc scores 51/100. Mixed. Strongest on financial health and value, quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 51 is built from 3 of 4 pillars, from 30% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✓ Reversal Evidence
- ~ Not-a-Value-Trap Gate
- ✕ Quality Floor
Pays no dividend. Every dollar of profit is reinvested into the business.
13F flows & insider trades land here.
Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives. Capricor is focused on the development of biologics, primarily cell and exos…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Immix Biopharma IncIMMX | 69 | $657.1M |
| Arbutus Biopharma CorpABUS | 49 | $627.0M |
| Geron Corp.GERN | 56 | $623.0M |
| Wave Life Sciences Inc.WVE | 54 | $617.3M |
| Pacific Biosciences of California, IncPACB | 40 | $613.3M |
| Climb Bio Inc.CLYM | 62 | $608.5M |
| Sana Biotechnology IncSANA | 34 | $605.3M |
| Evotec SEEVO | 51 | $561.8M |
| Phathom Pharmaceuticals, Inc.PHAT | 33 | $492.6M |
| Candel Therapeutics IncCADL | 45 | $486.4M |
Common questions
What sector and industry is Capricor Therapeutics in?
Capricor Therapeutics is in the Healthcare sector and the Drugs industry.
What is Capricor Therapeutics' Tenet Score?
Capricor Therapeutics' Tenet Score is 51 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




